Skip to search formSkip to main contentSkip to account menu

HyperCVAD/HD MTX AraC Regimen

Known as: Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone/High-dose Methotrexate-Cytarabine Regimen 
A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone (Hyper-CVAD) administered on a hyperfractionated schedule… 
National Institutes of Health

Related topics

Related topics

9 relations
CyclophosphamideCytarabineDexamethasoneDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Predictors of Delayed Clearance and Toxicities from High Dose Methotrexate in Patients Receiving Hypercvad Regimen for Treatment of Lymphoid Malignancies
Introduction: High dose Methotrexate (HDMTX) has been the backbone of chemotherapeutic regimens used for the treatment of… 
2013
2013
Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
2012
2012
Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance
We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or… 
2011
2011
Efficacy of Romiplostim in the Treatment of Chemotherapy Induced Thrombocytopenia (CIT) in a Patient with Mantle Cell Lymphoma
Chemotherapy induced thrombopenia (CIT) is difficult to treat, as previous treatment options, including recombinant human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)